Have you been diagnosed with
Multiple Myeloma (MM) and
plan to receive a
stem cell transplant?

If so, consider joining the GPC-100-001 study,
a Multiple Myeloma clinical trial that is investigating
a combination of 2 study drugs that may help collect
blood stem cells in people who are planning to receive
Autologous Stem Cell Transplant (ASCT).

Study participation helps impact progression in
Multiple Myeloma research.